Pharvaris Bv Stock In The News

PHVS Stock  USD 21.23  0.23  1.10%   
Our overall analysis of Pharvaris' news coverage and content from conventional and social sources shows investors' bearish mood towards Pharvaris BV. The specific impact of Pharvaris news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Pharvaris' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pharvaris headlines in addition to utilizing other, more conventional financial analysis modules. Check out Pharvaris Backtesting and Pharvaris Hype Analysis.

Pharvaris Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Pharvaris Announces Closing of $201.2 Mi...
https://www.globenewswire.com/news-release/2025/07/24/3121449/0/en/Pharvaris-Announces-Closing-of-201-2-Million-Upsized-Public-Offering-of-Ordinary-Shares-and-Pre-Funded-Warrants-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shar.html
 Neutral
Yahoo News
Pharvaris Announces Closing of $201.2 Mi...
https://finance.yahoo.com/news/pharvaris-announces-closing-201-2-200500536.html
 Neutral
seekingalpha News
Pharvaris prices $175M securities offering
https://seekingalpha.com/news/4470349-pharvaris-prices-175m-securities-offering?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
Investing News at Macroaxis
Pharvaris stock awaits pivotal HAE therapy data as BofA reiterates Underperform
https://www.investing.com/news/analyst-ratings/pharvaris-stock-awaits-pivotal-hae-therapy-data-as-bofa-reiterates-underperform-93CH-4130656
 Bullish
Macroaxis News: globenewswire.com
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025
https://www.globenewswire.com/news-release/2025/07/10/3113088/0/en/Pharvaris-Updates-Timing-of-Topline-Data-Announcement-for-RAPIDe-3-Pivotal-Phase-3-Study-to-the-Fourth-Quarter-of-2025.html
 Neutral
Macroaxis News: globenewswire.com
Pharvaris Announces Clinical Trial Data ...
https://www.globenewswire.com/news-release/2025/06/27/3106463/0/en/Pharvaris-Announces-Clinical-Trial-Data-Highlighting-Deucrictibant-for-the-Treatment-of-HAE-to-be-Presented-at-the-2025-US-HAEA-National-Summit.html
 Neutral
Investing News at Macroaxis
NodThera Announces Appointment of Elisabeth Björk as Board Member
https://www.investing.com/news/press-releases/nodthera-announces-appointment-of-elisabeth-bjark-as-board-member-93CH-4098878
 Bullish
Macroaxis News: globenewswire.com
Pharvaris Presents Data Highlighting the...
https://www.globenewswire.com/news-release/2025/06/16/3099673/0/en/Pharvaris-Presents-Data-Highlighting-the-Potential-for-Deucrictibant-to-Prevent-and-Treat-Bradykinin-Mediated-Angioedema-Attacks-at-the-EAACI-Congress.html
 Neutral
Macroaxis News: globenewswire.com
Pharvaris Announces Annual Meeting of Shareholders
https://www.globenewswire.com/news-release/2025/06/10/3096454/0/en/Pharvaris-Announces-Annual-Meeting-of-Shareholders.html
 Neutral
Macroaxis News: globenewswire.com
Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema
https://www.globenewswire.com/news-release/2025/06/02/3091694/0/en/Pharvaris-Presents-Data-Supporting-Ongoing-Clinical-Development-of-Deucrictibant-in-Bradykinin-Mediated-Angioedema.html
 Neutral

Pharvaris BV Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pharvaris and other traded companies coverage with news coverage. We help investors stay connected with Pharvaris headlines for the 7th of August to make an informed investment decision based on correlating the impacts of news items on Pharvaris Stock performance. Please note that trading solely based on the Pharvaris BV hype is not for everyone as timely availability and quick action are needed to avoid losses.
Pharvaris' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Pharvaris BV investors visualize upcoming and past events in order to time the market based on Pharvaris BV noise-free hype analysis.

Pharvaris Investors Sentiment

The influence of Pharvaris' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pharvaris. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pharvaris' public news can be used to forecast risks associated with an investment in Pharvaris. The trend in average sentiment can be used to explain how an investor holding Pharvaris can time the market purely based on public headlines and social activities around Pharvaris BV. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pharvaris' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pharvaris' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pharvaris' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pharvaris.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pharvaris in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pharvaris' short interest history, or implied volatility extrapolated from Pharvaris options trading.

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.